Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Saudi Oncology Society clinical management guidelines for renal cell carcinoma.
Bazarbashi S, Al Othman K, Al Otaibi M, Abusamra A, Rabah D, Aljubran A, Murshid E, Al Oraifi I, El-Naghi M, Bahader Y, Soudy H, Rehman A.
Urol Ann. 2011 Mar;3 Suppl:S3-5. doi: 10.4103/0974-7796.78548.
Similar articles
Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer.
Bazarbashi S, Omar A, Aljubran A, Alzahrani A, Alsanea N, Abduljabbar A, Alhomoud S, Ashari L, Balaraj K, Soudy H, Neimatallah M, Fagih M.
Hematol Oncol Stem Cell Ther. 2016 Dec;9(4):147-153. doi: 10.1016/j.hemonc.2016.08.004. Epub 2016 Sep 2.
Co-administration of intravesical bacillus Calmette-Guérin and interferon α-2B as first line in treating superficial transitional cell carcinoma of the urinary bladder.
Bazarbashi S, Soudy H, Abdelsalam M, Al-Jubran A, Akhtar S, Memon M, Aslam M, Kattan S, Shoukri M.
BJU Int. 2011 Oct;108(7):1115-8. doi: 10.1111/j.1464-410X.2010.10040.x. Epub 2011 Feb 18.
Awareness and Perceptions of Clinical Trials in Cancer Patients and Their Families in Saudi Arabia.
Bazarbashi S, Hassan A, Eldin AM, Soudy H, Hussain F.
J Cancer Educ. 2015 Dec;30(4):655-9. doi: 10.1007/s13187-015-0797-0.
Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer.
Bazarbashi S, Aljubran A, Alzahrani A, Mohieldin A, Soudy H, Shoukri M.
Cancer Med. 2015 Oct;4(10):1505-13. doi: 10.1002/cam4.497. Epub 2015 Jul 24.
Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial.
Abdelsalam M, Bazarbashi S, Abouzied M, Amin T, Soudy H, Rahal M, Darwish A.
Hematol Oncol Stem Cell Ther. 2010;3(4):179-84.
Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Bazarbashi S, Abdelsalam M, Amin T, El-Bassiouni M, Soudy H, Elweshi A, Alhusseiny H, Rehman K, Memon M, Ajarim D.
Chemotherapy. 2008;54(4):315-22. doi: 10.1159/000151353. Epub 2008 Aug 14.
A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer.
Bazarbashi S, El-Bassiouni M, Abdelsalam M, Soudy H, Sanea NA, Jabbar AA, Manji M, Fagih M, Ajarim D.
J Surg Oncol. 2008 Sep 1;98(3):167-74. doi: 10.1002/jso.21097.
Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
Akhtar S, Al-Sugair AS, Abouzied M, Alkadhi Y, Dingle M, Abdelsalam M, Soudy H, Darwish A, Eltigani A, Elhassan TA, Nabil-Ahmed M, Maghfoor I.
Bone Marrow Transplant. 2013 Nov;48(12):1530-6. doi: 10.1038/bmt.2013.88. Epub 2013 Jun 10.
Evaluation of adjuvant therapy in women with uterine papillary serous cancer.
Al Husaini H, Soudy H, Darwish A, Ahmed M, Eltigani A, Edesa W, Abdelsalam M.
Ann Saudi Med. 2012 Jan-Feb;32(1):27-31. doi: 10.5144/0256-4947.2012.27.
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H, Soudy H, Darwish A, Ahmed M, Eltigani A, Edesa W, Elhassan T, Omar A, Elghamry W, Al-Hashem H, Al-Hayli S, Madkhali I, Ahmad S, Al-Badawi IA.
Clin Transl Oncol. 2015 May;17(5):409-15. doi: 10.1007/s12094-014-1251-1. Epub 2014 Nov 15.
Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.
Bone Marrow Transplant. 2013 Apr;48(4):551-6. doi: 10.1038/bmt.2012.168. Epub 2012 Sep 10.
Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years.
Akhtar S, Youssef I, Soudy H, Elhassan TA, Rauf SM, Maghfoor I.
Bone Marrow Transplant. 2015 Dec;50(12):1551-6. doi: 10.1038/bmt.2015.178. Epub 2015 Aug 3.
Pure dysgerminoma of the ovary: a single institutional experience of 65 patients.
A L Husaini H, Soudy H, El Din Darwish A, Ahmed M, Eltigani A, A L Mubarak M, Sabaa AA, Edesa W, A L-Tweigeri T, Al-Badawi IA.
Med Oncol. 2012 Dec;29(4):2944-8. doi: 10.1007/s12032-012-0194-z. Epub 2012 Mar 10.
Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination.
Huang Y, Alzahrani NA, Liauw W, Soudy H, Alzahrani AM, Morris DL.
Eur J Surg Oncol. 2017 Dec;43(12):2292-2298. doi: 10.1016/j.ejso.2017.09.002. Epub 2017 Sep 28.
Filters: Manage Filters